A new trading day began on Tuesday, with Becton Dickinson & Co. (NYSE: BDX) stock price down -1.58% from the previous day of trading, before settling in for the closing price of $234.72. BDX’s price has ranged from $229.85 to $287.32 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 4.18% over the past five years. Meanwhile, its annual earnings per share averaged 6.10%. With a float of $288.48 million, this company’s outstanding shares have now reached $290.39 million.
Let’s look at the performance matrix of the company that is accounted for 73000 employees.
Becton Dickinson & Co. (BDX) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Instruments & Supplies Industry. The insider ownership of Becton Dickinson & Co. is 0.15%, while institutional ownership is 89.59%. The most recent insider transaction that took place on Mar 14 ’24, was worth 67,198. In this transaction SVP,Controller&Chief Acct Off of this company sold 282 shares at a rate of $238.29, taking the stock ownership to the 2,276 shares. Before that another transaction happened on Dec 11 ’23, when Company’s EVP & President Medical sold 1,239 for $232.46, making the entire transaction worth $288,018. This insider now owns 7,274 shares in total.
Becton Dickinson & Co. (BDX) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 264.94 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 6.10% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.65% during the next five years compared to 52.43% growth over the previous five years of trading.
Becton Dickinson & Co. (NYSE: BDX) Trading Performance Indicators
Here are Becton Dickinson & Co.’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.64. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.42. Likewise, its price to free cash flow for the trailing twelve months is 25.20.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 4.23, a number that is poised to hit 2.97 in the next quarter and is forecasted to reach 14.35 in one year’s time.
Technical Analysis of Becton Dickinson & Co. (BDX)
Becton Dickinson & Co. (NYSE: BDX) saw its 5-day average volume 0.96 million, a negative change from its year-to-date volume of 1.41 million. As of the previous 9 days, the stock’s Stochastic %D was 6.71%. Additionally, its Average True Range was 4.46.
During the past 100 days, Becton Dickinson & Co.’s (BDX) raw stochastic average was set at 1.56%, which indicates a significant decrease from 1.69% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 21.71% in the past 14 days, which was higher than the 17.74% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $240.19, while its 200-day Moving Average is $251.50. Nevertheless, the first resistance level for the watch stands at $233.83 in the near term. At $236.66, the stock is likely to face the second major resistance level. The third major resistance level sits at $238.22. If the price goes on to break the first support level at $229.45, it is likely to go to the next support level at $227.89. Assuming the price breaks the second support level, the third support level stands at $225.06.
Becton Dickinson & Co. (NYSE: BDX) Key Stats
With a market capitalization of 66.74 billion, the company has a total of 288,902K Shares Outstanding. Currently, annual sales are 19,372 M while annual income is 1,484 M. The company’s previous quarter sales were 4,706 M while its latest quarter income was 281,000 K.
